LITS

Lite Strategy, Inc. NASDAQ Listed Dec 18, 2003

Healthcare ·Biotechnology ·US · litestrategy.com

$1.14

Mkt Cap $41.5M

52w Low $0.95 2.4% of range 52w High $9.00

50d MA $1.16 200d MA $2.20

P/E (TTM) -0.5x

EV/EBITDA -0.7x

P/B 0.4x

Debt/Equity 0.0x

ROE -53.8%

P/FCF -1.4x

RSI (14) —

ATR (14) —

Beta 0.10

50d MA $1.16

200d MA $2.20

Avg Volume 302.8K

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

SIC Code

2834

CIK (SEC)

1262104

Phone

858 369 7100

9920 Pacific Heights Blvd. · San Diego, CA 92121 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 17, 2026	AMC	—	-0.82	—	1.10	-0.9%	+0.0%	+0.0%	+0.9%	-3.6%	+3.7%	—
Nov 14, 2025	AMC	—	-0.12	—	2.02	-3.5%	-5.9%	+1.6%	-7.8%	-4.5%	+0.0%	—
Sep 29, 2025	AMC	—	-0.40	—	2.54	-2.4%	-4.7%	+5.8%	+4.7%	-4.5%	+1.6%	—
May 13, 2025	AMC	—	-0.39	—	—	—	—	—	—	—	—	—
Dec 31, 2024	AMC	-2.20	-0.40	+81.7%	—	—	—	—	—	—	—	—
Sep 30, 2024	AMC	-1.70	-1.20	+29.3%	—	—	—	—	—	—	—	—
Jun 30, 2024	AMC	-1.41	-2.76	-96.4%	—	—	—	—	—	—	—	—
Mar 31, 2024	AMC	-1.49	-1.37	+7.9%	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	-1.41	-1.66	-17.5%	—	—	—	—	—	—	—	—
Nov 9, 2023	AMC	-1.79	8.46	+571.3%	—	—	—	—	—	—	—	—

Data updated apr 25, 2026 7:18pm · Source: massive.com